Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2025 Results
November 07, 2024 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue of $283.8 Million in Q2, Ahead of OutlookDiluted EPS of $1.09 in Q2, Up 2% Versus Prior YearNet Cash Provided by Operating Activities of Approximately $125 Million in First Six Months, Up...
Prestige Consumer Healthcare to Release Fiscal 2025 Second Quarter Earnings Results
October 08, 2024 08:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 second quarter earnings release on Thursday,...
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
September 03, 2024 08:00 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday,...
Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results
August 08, 2024 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue of $267.1 Million in Q1, Ahead of Expectations, down 4.4% versus Prior YearEPS of $0.98 and Adjusted EPS of $0.90 in Q1 Compared to $1.06 in the Prior YearCash from Operations of $54.8 Million...
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
July 02, 2024 16:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursday, August...
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
June 06, 2024 16:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference on...
Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results
May 14, 2024 17:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue of $277.0 Million in Q4 and $1,125.4 Million in Fiscal 2024Solid Consumption Trends in Q4 Offset by Near-Term Supply Chain ConstraintsAchieved Leverage Ratio of 2.8x at Year-End, Below...
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
April 25, 2024 08:30 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2024 fourth quarter and year-end earnings release on...
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag
April 03, 2024 11:57 ET
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine®. Seventy-five years later, Dramamine, a Prestige Consumer...
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results
February 08, 2024 06:00 ET
|
Prestige Consumer Healthcare Inc.
Revenue of $282.7 Million in Q3, Up 2.6% Versus Prior YearDiluted EPS of $1.06 in Q3, Up 2.2% Versus Prior YearReduced Leverage Ratio to 2.9x at Quarter EndRaising Full-Year Fiscal 2024 Earnings...